量化美国麻疹暴发的成本及成本随暴发规模的变化
该综述检索2000年至2025年美国50州的文献及官方报告,共提取19篇文献和8份灰色文献数据,覆盖暴发规模1至802例。估计每例平均暴发成本为43,203.65美元,每接触者平均成本443.46美元,固定响应成本297,746.94美元(95%CI:4,537.86-590,956.02),每增加一例的增量成本16,299.64美元(95%CI:15,301.96-17,297.32),总成本对暴发规模的弹性为0.86(95%CI:0.65-1.07)。
要点
- 每例麻疹暴发平均成本43,203.65美元,每接触者443.46美元。
- 成本随暴发规模扩大而增加,弹性为0.86(95%CI:0.65-1.07)。
核心结论
- 美国麻疹暴发持续再现并造成显著财务与公共卫生负担,但通过低成本高效疫苗及系统 preparedness 大多可预防。
- 固定响应成本可能很高,本研究分离出每例及每接触者的增量成本,有助于预算规划和模型风险评估。
研究设计与样本
- 共筛选120篇文章,33篇全文审查,从19篇文章提取数据,获得18个州的暴发相关成本,另识别8份灰色文献报告。
- 暴发规模范围为1至802例。
主要发现
- 每例平均暴发成本估计为43,203.65美元,每接触者平均成本为443.46美元。
- 每例平均成本从医疗提供者视角的33,415.75美元到包含公共卫生响应成本的58,591.50美元不等。
- 公共卫生响应固定成本估计为297,746.94美元(95%CI:4,537.86-590,956.02),每增加一例的增量成本为16,299.64美元(95%CI:15,301.96-17,297.32)。
- 总成本对暴发规模的弹性估计为0.86(95%CI:0.65-1.07)。
临床怎么用
- 可将每例增量成本和每接触者成本用于麻疹暴发的预算规划和模型风险评估。
- 应结合系统级准备以有效遏制暴发,并重视低成本高效麻疹疫苗接种的预防作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2025, the United States experienced the largest number of measles cases since its elimination in 2000. These outbreaks require extensive public health responses to mitigate, consume substantial hospital resources, and impose an economic and financial burden on state and federal budgets. We conducted a literature review using PubMed as well as official CDC and state health department reports to identify studies published between January 1, 2000, and October 7, 2025, across all 50 states. We also examined how costs scale with outbreak size. A total of 120 articles were screened, 33 underwent full text review, and data were extracted from 19 articles, yielding outbreak relevant costs in 18 different states. Eight additional reports in the gray literature were identified. Outbreak size ranged from 1 to 802 cases. Average outbreak cost per case was estimated at $43,203.65, while the average cost per contact was $443.46. Average cost per case varied from $33,415.75 from the medical provider perspective to $58,591.50 when including public health response costs. Fixed costs of imitating public health responses were estimated at $297,746.94 (95% CI: $4537.86 - $590,956.02), with an incremental cost of $16,299.64 (95% CI: $15,301.96 - $17,297.32) per each additional case. The elasticity of the total costs with respect to outbreak size was estimated at 0.86 (95% CI: 0.65-1.07) Measles outbreaks in the U.S. continue to re-emerge and impose significant financial and public health burden. These outbreaks are largely preventable through inexpensive and highly effective measles vaccination paired with system-level preparedness for effective containment. Since fixed response costs for any outbreak can be costly, our estimates provide improved data on how costs of measles outbreaks scale with outbreak size by isolating incremental costs associated incident new cases, as well as incident contacts, for use alongside budgetary planning and modeled risk assessments.
引用
- Sriudomporn S, Patenaude B. Quantifying the cost of measles outbreaks in the U.S. and how costs scale with outbreak size. Vaccine. 2026. PMID: 42617356. doi:10.1016/j.vaccine.2026.129040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。